Alpha Centric Advisors LLC Dynavax Technologies Corp Transaction History
Alpha Centric Advisors LLC
- $121 Million
- Q2 2024
A detailed history of Alpha Centric Advisors LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 130,000 shares of DVAX stock, worth $1.41 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
130,000
Previous 122,500
6.12%
Holding current value
$1.41 Million
Previous $1.52 Million
4.01%
% of portfolio
1.2%
Previous 1.05%
Shares
10 transactions
Others Institutions Holding DVAX
# of Institutions
259Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$238 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$118 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$102 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$86.4 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$77.5 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.37B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...